In the literature, many reports confirm that RAD51 G135C and G172T polymorphisms may be associated with the development of certain types of cancers [14, 15, 23–27], but little is known about their association with endometrial carcinoma. This evidence concerns the gene RAD51 and endometrial carcinoma.